Schering Claritin, Rebetol Await FDA Certification After Consent Decree
Executive Summary
Schering-Plough's first batch of products submitted to FDA for certification under a May 16 consent decree will include the Claritin 10 mg dose and the antiviral Rebetol
You may also be interested in...
GSK Consent Decree Sets “Aggressive” 150-Day Timeline For GMP Conformity
GlaxoSmithKline's consent decree mandates that the company notify the agency within 150 days of the corrective measures it has taken or plans to take in addressing FDA's good manufacturing practice concerns
GSK Signs GMP Consent Decree For Cidra Plant But Avoids Disgorgement Fee
Good manufacturing practices compliance efforts under GlaxoSmithKline's consent decree with FDA are likely to cost the company significantly less than Schering-Plough's 2002 agreement with the agency
GSK Signs GMP Consent Decree For Cidra Plant But Avoids Disgorgement Fee
Good manufacturing practices compliance efforts under GlaxoSmithKline's consent decree with FDA are likely to cost the company significantly less than Schering-Plough's 2002 agreement with the agency